PharmaKinetics Laboratories Inc.This Baltimore-based...

BY THE NUMBERS

May 19, 1992

PharmaKinetics Laboratories Inc.

This Baltimore-based drug-testing company reported earnings of $4.3 million for the three months that ended March 31, compared with a loss of $538,000 for a year ago. A profit also was reported for the nine months that ended March 31.

The company, which is operating under Chapter 11 protection, raised $5.9 million during the quarter by selling off its common stock holdings in Royce Laboratories. It also completed the sale last month of its German subsidiary to TSI Corp..

Three months ended 3/31/92

.. .. .. ..Revenue.. .. .. ..Net.. .. .. .. ..Share

'92 .. ..3,963,178.. .. .4,331,219.. .. .. ..0.40

'91.. .. .4,378,888.. .. (538,180).. .. .. (0.06)

% change.. .-9.5.. .. .. .. .--.. .. ... .. .. . --

Nine months ended 3/31/92

.. .. .. .Revenue.. .. .. ...Net.. .. .. .. ..Share

'92.. .10,751,302.. .. .$3,169,247.. .. .. .. 0.30

'91.. ..13,178,392.. ...(2,082,703).. .. ...(0.21)

% change . -18.4.. .. .. .. --.. .. .. .. .. .. .--

Oncor Inc.

This Gaithersburg company, which makes tests for the early detection of cancer, reported yesterday that it lost $3.1 million in the quarter that ended March 31, compared with a loss of $331,976 a year ago.

The company attributed part of the loss to a one-time cost of $1.4 million to buy out a contract with Hickley International Ltd. of Ireland, which helped develop a line of tests for colon, prostate, breast and bladder cancers.

The buyout ended the company's royalty payments to Hickley, said Stephen Turner, Oncor's chairman and chief executive.

Oncor said its net product sales increased 10 percent, to $1.1 million.

Three months ended 3/31/92

.. .. .. .. Revenue.. .. .. .. .Net.. .. .. ..Share

'92.. .. .1,107,238.. .. ..(3,110,351).. .. (0.24)

'91.. .. ..1,402,636.. .. ..(331,976).. .. .(0.04)

% change.. . 21.0.. .. .. .. ..--.. .. .. .. .. .--

Baltimore Sun Articles
|
|
|
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.